1. Semisynthetic analogues of the marine cembranoid sarcophine as prostate and breast cancer migration inhibitors.
- Author
-
Hassan HM, Sallam AA, Mohammed R, Hifnawy MS, Youssef DT, and El Sayed KA
- Subjects
- 4-Butyrolactone chemistry, 4-Butyrolactone pharmacology, 4-Butyrolactone therapeutic use, Animals, Anthozoa chemistry, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Cell Line, Tumor, Cell Migration Assays, Diterpenes chemical synthesis, Diterpenes chemistry, Diterpenes pharmacology, Diterpenes therapeutic use, Drug Screening Assays, Antitumor, Female, Humans, Indian Ocean, Male, Structure-Activity Relationship, 4-Butyrolactone analogs & derivatives, Antineoplastic Agents chemistry, Breast Neoplasms drug therapy, Cell Migration Inhibition drug effects, Cell Proliferation drug effects, Prostatic Neoplasms drug therapy
- Abstract
Sarcophine (1) is a bioactive cembranoid diterpene isolated from the Red Sea soft coral Sarcophyton glaucum. Previous semisynthesis attempts resulted in decreased or complete loss of 1's anticancer activity. Sarcophine and analogues showed antimigratory activity against breast and prostate cancer cell lines. This encouraged further semisynthestic optimizations to improve its activity and establish a preliminary structure-activity relationship. Eight new and five known semisynthetic analogues were generated. These compounds were evaluated for their ability to inhibit growth, proliferation, and migration of the prostate and breast metastatic cancer cell lines PC-3 and MDA-MB-231, respectively. Most analogues exhibited enhanced antimigratory activity., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF